Author:
Borelli Beatrice,Germani Marco Maria,Carullo Martina,Mattioni Roberto,Manfredi Bruno,Sainato Aldo,Rossi Piercarlo,Vagli Paola,Balestri Riccardo,Buccianti Piero,Morelli Luca,Antoniotti Carlotta,Cremolini Chiara,Masi Gianluca,Moretto Roberto
Reference108 articles.
1. A Study of Total Neoadjuvant , 2022.Therapy for High-risk Locally Advanced Rectal Cancer - Full Text View - ClinicalTrials.gov n.d. https://www.clinicaltrials.gov/ct2/show/NCT04543695 (accessed September 27, 2022).
2. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial;Akiyoshi;BMJ Open,2022
3. Alliance for Clinical Trials in Oncology, 2023. The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing The Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients With Locally Advanced Rectal Cancer. clinicaltrials.gov; 2023.
4. Ambraziene R. , 2022. Evaluation and Comparison of the Efficacy of a New Standard Pre-operative Chemotherapy for Stage II and III Colorectal Cancer According to the FOLFOX4 Regimen With Routine Chemoradiation Therapy. clinicaltrials.gov; 2022.
5. Safety and efficacy of anti–PD-1 antibody dostarlimab in patients (pts) with mismatch repair-deficient (dMMR) solid cancers: Results from GARNET study;Andre;JCO,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献